In a study investigating common profibrotic variants of MUC5B and desmoplakin (DSP), IPF patients receiving antifibrotic therapies and carrying the DSP rs2076295 G allele or the MUC5B rs35705950 T allele had reduced mortality [46]. This evidence concerns the gene DSP and idiopathic pulmonary fibrosis.